Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 30 | 31 | 29 | 329 | 31 |
| Cost of Goods | N/A | 0 | 0 | 0 | 1 |
| Gross Profit | N/A | 31 | 29 | 329 | 30 |
| Operating Expenses | 13,077 | 12,170 | 13,819 | 10,378 | 11,115 |
| Operating Income | -13,047 | -12,139 | -13,790 | -10,049 | -11,085 |
| Other Income | -2,431 | 8,807 | 670 | 7,650 | -40,856 |
| Pre-tax Income | -15,478 | -3,332 | -13,120 | -2,399 | -51,941 |
| Net Income Continuous | -15,478 | -3,332 | -13,120 | -2,399 | -51,941 |
| Net Income | $-15,478 | $-3,332 | $-13,120 | $-2,399 | $-51,941 |
| EPS Basic Total Ops | -0.18 | -0.04 | -0.16 | -0.03 | -0.92 |
| EPS Basic Continuous Ops | -0.18 | -0.04 | -0.16 | -0.03 | -0.92 |
| EPS Diluted Total Ops | -0.18 | -0.04 | -0.16 | -0.03 | -0.92 |
| EPS Diluted Continuous Ops | -0.18 | -0.04 | -0.16 | -0.03 | -0.92 |
| EBITDA(a) | $-12,648 | $-11,778 | $-13,428 | $-9,679 | $-10,722 |